Mild-to-moderate COVID-19

Active Ingredient: Bamlanivimab

Indication for Bamlanivimab

Population group: only adolescents (12 years - 18 years old)

Treatment of mild-to-moderate COVID-19 in patients aged ≥12 years who weigh ≥40 kg with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization.

Patient selection

High-risk defined as meeting at least 1 of these criteria:
Chronic kidney disease
Diabetes
Immunosuppressive disease
Receiving immunosuppressive treatment

Additional high-risk factors in patients aged 12-17 years:
BMI ≥85th percentile for their age and sex based on CDC growth charts
Sickle cell disease
Congenital or acquired heart disease
Neurodevelopmental disorders (eg, cerebral palsy)
Medical-related technological dependence (eg, tracheostomy, gastrostomy, positive-pressure ventilation [not related to COVID-19])
Asthma, reactive airway diease, or other chronic respiratory disease requiring daily medication for control

For this indication, competent medicine agencies globally authorize below treatments:

700 mg once

Route of admnistration

Intravenous

Defined daily dose

700 - 700 mg

Dosage regimen

From 700 To 700 mg once every day

Detailed description

700 mg as a single IV infusion over 60 minutes

Administer as soon as possible after positive viral test for SARS-CoV-2 and within 10 days of symptom onset in patients at high-risk for progressing to severe COVID-19 and/or hospitalization.

Dosage considerations

Single IV infusion over 60 minutes.

Active ingredient

Bamlanivimab

Bamlanivimab is a recombinant, neutralizing human IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2. It is designed to block viral attachment and entry into human cells, thus neutralizing the virus, potentially treating COVID-19.

Read more about Bamlanivimab

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.